Site Search

... biomarker testing – a routine step in accessing personalized medicine treatments that have become an increasingly important part of cancer care in recent years due to their significant impact in improving survivorship and quality of life.   Progress in the fight against cancer has ... “By aligning coverage for biomarker testing with the latest science, we can help increase access to precision medicine that can lead to better health outcomes, improved quality of life and potentially reduce costs by allowing some Floridians to bypass costly and ineffective treatments, and ...   0 Rep. Gonzalez Pittman Introduces Bill to Allow More Floridians to Access Routinely Recommended Testing That Allows Doctors to Personalize Health Care Treatments to Target Specific Cancer Growth Lawmakers Take Critical Step to Revolutionize Cancer Treatment in Florida, State’s Second ...

... each year, screen more residents and prevent disease progression. Expand access to biomarker testing for patients covered by state-regulated health plans, including Medicaid. Insight gained from biomarker testing can be used to help guide medical treatment in cervical and other cancers. ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...

... making it less punitive for patients and easier for them to weather the financial storm of their illness. ACS CAN, along with the many public health and medical leaders who advocated for the passage of the proposal, see it as an opportunity to minimize the negative, cascading impacts of medical debt. This legislative session, the mother-daughter duo will join fellow patient advocates, medical leaders and public health allies in advancing legislation to improve access to biomarker testing, eliminate financial barriers to prostate cancer screening and end ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...

... Trials Day on the 20th, the American Cancer Society Cancer Action Network (ACS CAN) joins cancer survivors and caregivers as well as key public health, patient and provider groups from across New York in calling on state lawmakers to support legislation that can improve access to clinical ... trials. Clinical trials are critical to medical innovation, advancing potential new cancer treatments from the research setting to the cancer care clinic. Increasingly, cancer clinical trials are driven by biomarker testing and the development of targeted therapies. Patients’ biomarker ... that involve biomarkers growing from 15% in 2000 to 55% in 2018.” Senate Bill 1196 / Assembly Bill 1673 would require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing in cases where patients can benefit thereby increasing many New ...